Oncology
Cancer takes. Takes away loved ones, time and untapped potential. At Boehringer Ingelheim we are providing new hope for patients by taking cancer on. We are collaborating with the oncology community to deliver scientific breakthroughs to transform the lives of patients. Our primary focus is in lung and gastrointestinal cancers, with the goal of delivering breakthrough, first-in-class treatments that can help win the fight against cancer. Our commitment to innovation has resulted in pioneering treatments for lung cancer and we are advancing a unique pipeline of cancer cell directed agents, immune oncology therapies and intelligent combination approaches to help combat many cancers.
-
Oncology
At Boehringer Ingelheim, we believe this can be the generation that redefines many cancers as curable diseases. We want to be part of this transformation.
-
Darryl McConnell Ph.D. Research Site Head, Vienna, Austria
Innovation Disease Focus
Learn from Darryl McConnell, Research Site Head at Boehringer Ingelheim Regional Centre, Vienna, how he and his team are tackling the “beating heart of cancer”
-
Victoria Zazulina
Oncology
Dr Victoria Zazulina explains Boehringer Ingelheim’s commitment to patients with GI cancers and the ambition to transform this treatment space.
-
Taking Cancer on Through Flavour
-
Human Pharma Pipeline
Pipeline
This represents a selection of assets in our research and development portfolio in November 2019.
-
A Unique Bond: he picked me
Oncology
After being diagnosed with cancer Helga has many tough decisions to make. An easy decision for her was to introduce Brumbi to the family.
-
Oncology
Learn how Darryl McConnell & his team are tackling one of the biggest scientific conundrums.
-
DOWNLOAD PDF (2.54 MB)
Results from a global survey on treatment considerations and selection in EGFR M+ NSCLC
-
Oncology
Dr. Jonathon Sedgwick explains the ways in which immuno-oncological drugs enable the immune system to fight cancer.
-
Oncology
Hear Uday Bose, Head of Marketing Oncology, explain why collaborating with patient focused organizations is critical to meet the patients’ needs.
-
Oncology
Our collaborative approach is grounded in mutual trust, shared goals and a passion for leading science.
-
Oncology
Prof. Dr. Norbert Kraut, Head of Global Cancer Research, illustrates the innovative approaches we are pursuing in cancer therapy.
-
Oncology
For more than 20 years, we are taking cancer on by developing novel therapies with attention to two indication areas: lung cancer and gastrointestinal tumors.
-
Working Together in Oncology
Innovation Disease Focus
-
-
Kath
Lung Cancer
-
How scientific congresses drive patient benefit
Oncology
What is happening behind the doors of congress centers? How do patients benefit from the participation of pharmaceutical representatives? Let’s shed some light.
-
When it comes to outsmarting cancer we are brighter together
Oncology
Innovative research to improve lives for patients with cancer